These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia]. Elie R; Gagnon MA; Gauthier R; Jéquier JC Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906 [No Abstract] [Full Text] [Related]
4. [Letter: Tardive dyskinesia, a little-known extrapyramidal syndrome due to therapy with neuroleptics]. Berchtold P; Hinssen M; Irmscher K Dtsch Med Wochenschr; 1974 Mar; 99(9):420-1. PubMed ID: 4151333 [No Abstract] [Full Text] [Related]
6. [Statokinesimetric and clinical study of extrapyramidal disorders induced by neuroleptics in a population of mental patients]. Andersson JC; Morel P; Poilpre E; Baron JB Agressologie; 1977; 18 Spec No():35-43. PubMed ID: 900359 [No Abstract] [Full Text] [Related]
7. [Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs]. Bukowczyk A; Wasik A; Horodnicki J Psychiatr Pol; 1974; 8(2):143-8. PubMed ID: 4830321 [No Abstract] [Full Text] [Related]
8. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities]. Bordeleau JM; Tétreault L; Elie R Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390 [No Abstract] [Full Text] [Related]
9. [Extra-pyramidal syndrome caused by neuroleptics]. Lambert PA Encephale; 1973; 62(1):78-105. PubMed ID: 4718697 [No Abstract] [Full Text] [Related]
11. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs]. Ferrari P; Robotti E; Nardini M Boll Chim Farm; 1972 Oct; 111(10):610-5. PubMed ID: 4566407 [No Abstract] [Full Text] [Related]
12. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action. Huygens H; Vereecken JL; Tanghe A Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374 [No Abstract] [Full Text] [Related]
13. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses? Neu C; Dimascio A; Demirgian E Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975 [No Abstract] [Full Text] [Related]
14. [ON THE CLINICAL ASPECTS AND THERAPY OF PYRAMIDAL AND EXTRAPYRAMIDAL MOVEMENT DISORDERS]. RETT A Wien Klin Wochenschr; 1963 Oct; 75():772-5. PubMed ID: 14093592 [No Abstract] [Full Text] [Related]
15. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton]. Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112 [No Abstract] [Full Text] [Related]
16. [Neuroleptic manifestations in daily practice]. Stojanović T; Savić B; Todorović M Med Pregl; 1978; 31(1-2):63-5. PubMed ID: 651834 [No Abstract] [Full Text] [Related]
17. [Morpho-functional changes in the pyramidal and extrapyramidal systems due to triftazin]. Krivitskaia GN; Sysoeva AF Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(7):1063-8. PubMed ID: 4627828 [No Abstract] [Full Text] [Related]
18. [Clinical trial of tropatepine chlorhydrate as a corrector of syndromes due to neuroleptics]. Delaunay J; Guibert S Ann Med Psychol (Paris); 1976 Jan; 1(1):144-7. PubMed ID: 970819 [No Abstract] [Full Text] [Related]
19. [Extrapyramidal motor disorders in neuroleptic therapy (apparent recurring luxation of mandibular joints)]. von Domarus H Dtsch Zahnarztl Z; 1973 Nov; 28(11):1085-8. PubMed ID: 4520088 [No Abstract] [Full Text] [Related]